Back
Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

This Could Be The Most Profitable 9 Minutes Of Your Life
See his program for yourself here.
Sell
44
REGN
Regeneron Pharmaceuticals
Last Price:
724.74
Seasonality Move:
8.4%
7 Day Trial
ALL ACCESS PASS
$
7

[BREAKING] Pentagon to Spend Billions on "Living Missile"
Get the name of the company here >>>Regeneron Pharmaceuticals Price Quote
$724.74
-0.31 (-0.04%)
(Updated: May 27, 2023 at 5:28 AM ET)
Regeneron Pharmaceuticals Key Stats
Sell
44
Regeneron Pharmaceuticals (REGN)
is a Sell
Day range:
$719.00 - $726.77
52-week range:
$538.01 - $837.55
Dividend yield:
0%
P/E ratio:
18.97
P/S ratio:
6.67
P/B ratio:
3.39%
Volume:
742.5K
Avg. volume:
540.1K
1-year change:
6.09%
Market cap:
$79.5B
Revenue:
$12.2B
EPS:
$36.8
How Much Does Regeneron Pharmaceuticals Make?
-
How Much Are Regeneron Pharmaceuticals's Sales Annually?
REGN Revenues are $12.2B -
How Much Profit Does Regeneron Pharmaceuticals's Make A Year?
REGN net income is $4.3B
Is Regeneron Pharmaceuticals Growing As A Company?
-
What Is Regeneron Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.07% -
What Is Regeneron Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is -0.17%
Regeneron Pharmaceuticals Stock Price Performance
-
Did Regeneron Pharmaceuticals Stock Go Up Last Month?
Regeneron Pharmaceuticals share price went down by -6.81% last month -
Did REGN's Share Price Rise Over The Last Year?
REGN share price rose by 6.09% over the past 1 year
What Is Regeneron Pharmaceuticals 52-Week High & Low?
-
What Is Regeneron Pharmaceuticals’s 52-Week High Share Price?
Regeneron Pharmaceuticals has traded as high as $837.55 over the past 52 weeks -
What Is Regeneron Pharmaceuticals’s 52-Week Low Share Price?
Regeneron Pharmaceuticals has traded as low as $538.01 over the past 52 weeks
Regeneron Pharmaceuticals Price To Free Cash Flow
-
Is Regeneron Pharmaceuticals Stock Overvalued?
Regeneron Pharmaceuticals is trading at a price to free cash flow ratio of 32.64 -
Is Regeneron Pharmaceuticals Stock Undervalued?
Regeneron Pharmaceuticals EV to Free Cash Flow ratio is 28.72 -
What Is Regeneron Pharmaceuticals’s Price Earnings Growth Ratio?
REGN PEG ratio is 0.00 -
Is Regeneron Pharmaceuticals Trading At A Premium To Earnings?
Regeneron Pharmaceuticals EV to EBIT ratio is 15.38
Is It Risky To Buy Regeneron Pharmaceuticals?
-
How Much Debt Does Regeneron Pharmaceuticals Have?
Total long term debt quarterly is $2B -
How Much Cash Does Regeneron Pharmaceuticals Have?
Cash and short term investments quarterly total is $9B -
What Is Regeneron Pharmaceuticals’s Book Value Per Share?
Book value per share is 214.18
Is Regeneron Pharmaceuticals Cash Flow Positive?
-
What Is REGN Cash Flow From Operations?
Cash flow from operations (TTM) is $4.3B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$1.4B -
What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$2.3B
Regeneron Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
REGN return on invested capital is 17.71% -
What Is Regeneron Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 14.88% -
What Is REGN Return On Equity?
ROE is a measure of profitability and is 19.33%
Regeneron Pharmaceuticals Earnings Date & Stock Price
-
What Is Regeneron Pharmaceuticals's Stock Price Today?
A single share of REGN can be purchased today for 725.05 -
What Is Regeneron Pharmaceuticals’s Stock Symbol?
Regeneron Pharmaceuticals trades on the S&P500 under the ticker symbol: REGN -
When Is Regeneron Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Regeneron Pharmaceuticals is scheduled on August 3, 2023 -
When Is REGN's next ex-dividend date?
Regeneron Pharmaceuticals's next ex-dividend date is May 27, 2023 -
How To Buy Regeneron Pharmaceuticals Stock?
You can buy Regeneron Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Regeneron Pharmaceuticals Competitors
-
Who Are Regeneron Pharmaceuticals's Competitors?
Below is a list of companies who compete with Regeneron Pharmaceuticals or are related in some way:
Regeneron Pharmaceuticals Dividend Yield
Data Unavailable
Regeneron Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | -16.73% | 5.55% |
Revenue: | 6.64% | 5.48% |
Analyst Recommendations
Buy Recommendations: | 10 |
---|---|
Hold Recommendations: | 8 |
Sell Recommendations: | 0 |
Price Target: | 883.78 |
Upside from Last Price: | 21.89% |